Semler Scientific, Inc. (SMLR)

Semler Scientific's stock price has experienced fluctuations over the past six months. The stock price declined by 61.51% over the last 12 months, though it saw a 13.87% increase in the past month as of early January 2026. A major event impacting the stock was the proposed merger with Strive Asset Management, which shareholders approved. Semler Scientific's stock dropped approximately 11% on the day of the approval. The company reported a 17% decrease in total revenues in Q3 2024 compared to Q3 2023. In Q2 2025, Semler's Bitcoin treasury of 5,021 BTC produced $110.4 million in unrealized gains year-to-date. The company also issued and sold over 5 million shares through an ATM equity offering, raising $203.8 million in net proceeds.

Semler Scientific has observed seasonality in its variable-fee revenues, with the latter half of the year experiencing softer revenues compared to the first half in both 2021 and 2022. The first half of 2023 showed strong performance, with both fixed-fee and variable-fee revenues reaching record highs. The company continues to see strong demand from home risk assessment customers utilizing QuantaFlo for PAD during in-home examinations.

Semler Scientific, Inc. is a healthcare technology company based in the United States, specializing in risk assessment and diagnostic solutions for chronic diseases. Their primary product is QuantaFlo®, a four-minute in-office blood flow test used to measure arterial blood flow in the extremities. The company also offers the WellChec multi-test service platform, which evaluates patients for chronic diseases. Semler Scientific markets its products to insurance plans, physicians, integrated delivery networks, independent physician groups, and risk assessment groups. In 2024, Semler Scientific adopted Bitcoin as its primary treasury reserve asset.

Semler Scientific, Inc. is headquartered in Campbell, California, United States. The company provides technology solutions to healthcare providers primarily in the United States, distributing its products through sales representatives and distributors.

Semler Scientific's brand reputation has been influenced by its strategic adoption of Bitcoin as a primary treasury reserve asset in 2024. The proposed acquisition by Strive Asset Management has introduced some reputational challenges, as investors have expressed skepticism, leading to a drop in Semler Scientific's stock price post-approval.

Semler Scientific, Inc. has a mixed ownership structure, with approximately 62.99% of the company's stock held by institutional shareholders and 37.01% by insiders. Major institutional owners include Interchange Capital Partners, LLC, Morgan Stanley, and BlackRock, Inc. Key individual insider owners include Herbert J. Semler, William H. Chang, and Eric Semler.